Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Completion or Enrollment in the Phase III Confirmatory Study of KIACTA™
Thursday, May 29, 2014
KIACTA™ Phase III Confirmatory Study expected to be completed in 2016.
Sciformix to Reveal Strategic Model for Talent Acquisition at the DIA 50th Annual Meeting
Thursday, May 22, 2014
New career strategy aims to address talent acquisition and retention requirements for capacity expansion.
Aptiv Solutions Improves Accuracy of Dose Escalation Studies with Launch of ADDPLAN® DF 3.0
Friday, May 16, 2014
ADDPLAN® DF 3.0 incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials.
Da Volterra's DAV132 Shown As Promising Candidate for Preventing Severe C. Difficile Infections
Tuesday, May 13, 2014
The CL1001 clinical trial also demonstrated the adequate targeted delivery of DAV132 to the ileum and the colon and its adsorbing effects.
Cleanroom Services Partnership Brings Synergy for Customers
Thursday, May 01, 2014
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.
Quotient Clinical Extends its Translational Pharmaceutics™ Platform
Friday, April 25, 2014
Company will employ its manufacturing capabilities to supply specialist oncology centers with drug products.
New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.
Critical Pharmaceuticals, The University of Nottingham and NUH Starts First Phase I Clinical Trial
Wednesday, April 16, 2014
Phase I clinical trial on a nano-enabled intranasal teriparatide for the treatment of osteoporosis.
ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.
Showing Results 41 - 50 of 326
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to
modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!